Approval · Notice of Compliance 4999 · 1995
PERSANTINE: Notice of Compliance 4999
Issued March 15, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4999
- Date
- March 15, 1995
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Coronary vasodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERSANTINE | Not yet assigned | — |
Medicinal ingredients
- DIPYRIDAMOLE 25 MG per TAB
- DIPYRIDAMOLE 50 MG per TAB
- DIPYRIDAMOLE 75 MG per TAB
- DIPYRIDAMOLE 100 MG per TAB
- DIPYRIDAMOLE 5 MG per ML